Additional findings in prostate MRI

Fabio Porões1,2, Paraskevi Karampa3,4, Thomas Sartoretti3

  • 1University of Fribourg, Fribourg, Switzerland. fabio.ramosporoes@unifr.ch.

Abstract

Insights

Extended prostate MRI protocols identify significant additional findings, including prostate cancer (PCa)-related abnormalities impacting patient management. While many findings are clinically significant, changes in management for non-PCa related findings are less common.

Area of Science:

  • Radiology
  • Oncology
  • Medical Imaging

Background:

  • Extended prostate MRI protocols are utilized despite growing interest in abbreviated methods.
  • Assessing the clinical value of additional findings (AFs) from extended protocols is crucial for patient care.

Purpose of the Study:

  • To evaluate the benefits of an extended prostate MRI protocol.
  • To quantify the number and clinical significance of additional findings (AFs).
  • To determine the impact of AFs on patient management.

Main Methods:

  • Retrospective analysis of 1282 patients undergoing prostate MRI.
  • Classification of extra-prostatic findings based on relation to prostate cancer (PCa) and clinical significance (Groups 1-3).
  • Evaluation of management changes resulting from significant AFs.

Main Results:

  • Over 5000 AFs were identified in 1240 patients.
  • Extra-prostatic PCa-related AFs occurred in 8.3% of patients, altering disease stage and management.
  • Clinically significant AFs (Groups 2 and 3) represented over one-third of all findings.

Conclusions:

  • Extended prostate MRI protocols yield a high prevalence of clinically significant AFs, both PCa-related and unrelated.
  • PCa-related extra-prostatic AFs significantly impact patient management in a notable percentage of cases.
  • Management changes due to non-PCa related significant AFs are less frequent, suggesting a resource-dependent protocol selection.